Skip to content

Effects of Osteopathic Management on Disability and Quality of Life After Lumbar Arthrodesis

Effects of Osteopathic Management on Disability and Quality of Life After Lumbar Arthrodesis. A PARALLEL, RANDOMIZED AND DOUBLE-BLIND CONTROLLED PILOT STUDY

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06802120
Acronym
OSTEODESE
Enrollment
40
Registered
2025-01-31
Start date
2025-01-02
Completion date
2027-05-31
Last updated
2026-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chirurgical Intervention

Brief summary

The aim of our study is to assess the effect of a combined physiotherapy and osteopathy treatment versus a placebo on the management of disability and quality of life after lumbar arthrodesis. This study will provide a better assessment of the use of osteopathy as a non pharmacological approach to post-operative management. For this purpose, We will analyze the effects of these two approaches, targeted and non-targeted osteopathy (TO vs. NTO), on patients' disability and quality of life after surgery.

Interventions

OTHERosteopathy real

treatment with real osteopathy 2 times a week for 8 weeks

treatment with sham osteopathy 2 times a week for 8 weeks

Sponsors

Institut De La Colonne Vertebrale Et Des Neurosciences
CollaboratorOTHER
Ecole Supérieur d'Ostéopathie
CollaboratorOTHER
Clinique Bizet
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* having experienced a lumbar arthrodesis (of one to three levels) four weeks before inclusion * being under a stable pharmacological treatment over the last month * who are suffering from postoperative mechanical pain (VAS ≥ 4)

Exclusion criteria

* neuropathic pain according to a DN4 score greater than or equal to 4/10, * are suffering from fibromyalgia, * algodystrophy, * other somatic or neuropsychiatric diseases (other than depression and anxiety), * have received osteopathic treatment over the last three month prior to inclusion, * are included in another interventional research protocol during the study period

Design outcomes

Primary

MeasureTime frameDescription
Disability will be assessed using the ODQbaseline and Week 8Oswestry Low Back Pain Disability Questionnaire * Minimum Value: 0 * Maximum Value: 100 * Interpretation: Higher scores indicate a worse outcome =\> greater disability due to low back pain.

Secondary

MeasureTime frameDescription
Pain and disability measuresbaseline, ans every week from 1 to 8The Visual Analog Scale is a subjective measurement tool commonly used to assess the intensity of pain. It consists of a horizontal 10-centimeter line on which the patient marks a point that reflects their experience. Minimum and maximum values: 0 = complete absence of the symptom 10 = the most severe imaginable intensity of the symptom Score interpretation: Higher scores indicate greater symptom intensity Lower scores indicate lesser intensity
The Osteopathic Dysfunction Palpation Assessment Scalebaseline and Week 8Osteopathic Dysfunction Palpation Assessment Scale Minimum value: 0 (no dysfunction detected) Maximum value: Each anatomical structure (e.g., ilium, pubis, sacrum, spine, etc.) is assessed on 4 criteria: mobility, viscoelasticity, texture, temperature. For each criterion, the score is 0 or 1 (absence or presence of dysfunction). For each structure, the maximum score is therefore 4. The total maximum score depends on the number of structures assessed Interpretation: The higher the score, the greater the osteopathic dysfunction (so a higher score indicates a worse outcome)

Countries

France

Contacts

Primary ContactBouchra benkessou, PM
b.benkessou@hexagone-sante-paris.fr0033140693525
Backup ContactGeorges ABI LAHOUD, Professeur

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026